COVID mink analysis shows mutations are not dangerous - yet.

  title={COVID mink analysis shows mutations are not dangerous - yet.},
  author={Smriti Mallapaty},
  • S. Mallapaty
  • Published 1 November 2020
  • Medicine, Biology
  • Nature
The Up state of the SARS-COV-2 Spike homotrimer favors an increased virulence for new variants
Analysis of possible molecular mechanisms responsible for the increased transmissibility and the increased rate of hospitalizations related to variants of SARS-CoV-2 showed that the increased virulence is more likely to be due to the improved stability to the S trimer in the opened state than due to alterations in the complexation RBD-ACE2. Expand
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
The structural findings provide mechanistic insights into how this antibody can accommodate antigenic variation in these viruses and provide valuable information for vaccine and therapeutic design to address current and future antigenic drift in SARS-CoV-2 and to protect against zoonotic coronaviruses. Expand
Review: SARS-CoV-2 infection in farmed minks – an overview of current knowledge on occurrence, disease and epidemiology
The current data indicate that further studies on minks and other Mustelidae are needed to clarify whether they may be a potential reservoir for SARS-CoV-2, and if so, how and whether this can be prevented. Expand
Up State of the SARS-COV-2 Spike Homotrimer Favors an Increased Virulence for New Variants
The COVID-19 pandemic has spread worldwide. However, as soon as the first vaccines—the only scientifically verified and efficient therapeutic option thus far—were released, mutations combined intoExpand
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
This study reports on crystal structures of a cross-neutralizing antibody CV38-142 in complex with the receptor binding domains from SARS-CoV-2 and SARV, allowing the antibody to accommodate antigenic variation in these viruses. Expand
Advances in the computational analysis of SARS-COV2 genome
The results of the synergistic approach reveal the complex time dynamics of the evolutionary process and may help to clarify future directions of the SARS-CoV-2 evolution. Expand
COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles?
Ultimately, the skeptical opinion on the comprehensive administration of such antiviral nanotheranostics, even when integrated into facemasks, is expressed, because of their reported toxicities and the different NP parameters that govern their end toxicity. Expand
COVID-19 and Hypertension: The What, the Why, and the How
This review summarizes the current understanding of the link between hypertension and COVID-19 and its underlying mechanisms and concludes that there is still much to be learn from this novel coronavirus. Expand
COVID-19 in Farm Animals: Host Susceptibility and Prevention Strategies
COVID-19 is caused by the virus SARS-CoV-2 that belongs to the family of Coronaviridae, which has affected multiple species and demonstrated zoonotic potential and its long-term impacts are still not clear. Expand
Effect of RBD (Y453F) mutation in spike glycoprotein of SARS-CoV-2 on neutralizing IgG affinity.
Raising a concern that infection of SARS-CoV-2 mutants that cause serious symptoms in humans may spread globally, studies suggest that virus variants with RBD Y453F mutation partially escaped detection by four neutralizing monoclonal antibodies and neutralizing antibodies in serum. Expand